Data for the years 2021 & 2022 are preliminary. Due to the impact of the COVID-19 pandemic, data for the year 2020 should be interpreted with caution. Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.
COVID-19 disruptions in HIV, diagnosis, care and reporting of deaths during 2020 have also made incidence, prevalence, and knowledge of status estimates derived from a CD4-based model, unreliable. Therefore, the HIV surveillance supplemental report Estimated HIV Incidence and Prevalence in the U.S., which provides data on estimated incidence, prevalence, and knowledge of status in the U.S., was not published by CDC this year.

Target Values for the EHE Indicators | AHEAD

Data Methods

Learn more about the data that informs AHEAD.

Two people looking at each other, smiling

Target Values for the EHE Indicators

For Incidence indicator icon incidence and Diagnoses indicator icon diagnoses, the stated EHE 2030 goal is a 90% reduction from baseline year (2017) and the stated 2025 target is a 75% reduction; the 2030 and 2025 targets for both incidence and diagnoses were calculated as follows:

  1. 2030: Calculate 90% from baseline using the formula: 2017 baseline value*0.10
  2. 2025: Calculate 75% from baseline using the formula: 2017 baseline value*0.25

The stated 2030 and 2025 target values for other EHE indicators are as follows:

  • Knowledge of Status indicator icon Knowledge of status: 95%
  • Linkage to Care indicator icon Linkage to care: 95%
  • Viral Suppression indicator icon Viral suppression: 95%
  • PrEP Coverage indicator icon PrEP coverage: 50%

For more information on target values for the EHE indicators, please refer to the following reports:

  1. U.S. Department of Health and Human Services. February 26, 2020. What is ‘Ending the HIV Epidemic: A Plan for America’? [Online]. HIV.gov. Available at https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/overview (Accessed: March 5, 2020).
  2. Harris NS, Johnson AS, Huang YA, et al. Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis — United States, 2013–2018. MMWR Morb Mortal Wkly Rep 2019;68:1117–1123. DOI: http://dx.doi.org/10.15585/mmwr.mm6848e1external icon